Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy

Anne Montfort¹, Céline Colacios^{1

2}, Thierry Levade^{1

2

3}, Nathalie Andrieu-Abadie¹, Nicolas Meyer^{1

2

4}, Bruno Ségui^{1

2}

Affiliations

¹ INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
² Université Toulouse III - Paul Sabatier, Toulouse, France.
³ Laboratoire de Biochimie, Institut Fédératif de Biologie, CHU Purpan, Toulouse, France.
⁴ Dermatologie, Institut Universitaire du Cancer (IUCT-O) et CHU de Toulouse, Toulouse, France.

Published Erratum

Anne Montfort et al. Front Immunol. 2019.

. 2019 Oct 22:10:2515.

doi: 10.3389/fimmu.2019.02515. eCollection 2019.

Anne Montfort¹, Céline Colacios^{1

2}, Thierry Levade^{1

2

3}, Nathalie Andrieu-Abadie¹, Nicolas Meyer^{1

2

4}, Bruno Ségui^{1

2}

¹ INSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
² Université Toulouse III - Paul Sabatier, Toulouse, France.
³ Laboratoire de Biochimie, Institut Fédératif de Biologie, CHU Purpan, Toulouse, France.
⁴ Dermatologie, Institut Universitaire du Cancer (IUCT-O) et CHU de Toulouse, Toulouse, France.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.01818.].

Keywords: CTLA-4; PD-1; immune escape; melanoma; tumor necrosis factor (TNF).

The TNF Paradox in Cancer Progression and Immunotherapy.
Montfort A, Colacios C, Levade T, Andrieu-Abadie N, Meyer N, Ségui B. Montfort A, et al. Front Immunol. 2019 Jul 31;10:1818. doi: 10.3389/fimmu.2019.01818. eCollection 2019. Front Immunol. 2019. PMID: 31417576 Free PMC article. Review. No abstract available.